Epoprostenol is not the sort of medicine that quietly waits in a bathroom cabinet beside the bandages. It is a powerful, continuously infused treatment for pulmonary arterial hypertension, delivered through an intravenous catheter by a portable pump that must keep working around the clock.
That may sound intimidating, and treatment certainly requires training and planning. However, epoprostenol can improve exercise capacity, reduce strain on the right side of the heart, and help some people with advanced pulmonary arterial hypertension breathe and function more comfortably. This guide explains how Veletri and the former Flolan brand work, what the medication looks like, how dosing is managed, which side effects deserve attention, and why a backup pump is not optional luggage.
Epoprostenol at a Glance
| Generic name | Epoprostenol |
|---|---|
| Current U.S. brand | Veletri |
| Former U.S. brand | Flolan, discontinued by its manufacturer in November 2025 |
| Drug class | Prostacyclin vasodilator and platelet-aggregation inhibitor |
| Primary approved use | WHO Group 1 pulmonary arterial hypertension |
| Administration | Continuous intravenous infusion through a central venous catheter and ambulatory pump |
| Typical labeled starting dose | 2 nanograms per kilogram per minute, adjusted by a specialist |
| Major safety issue | Abrupt interruption can cause rapid rebound pulmonary hypertension |
Veletri remains available in the United States. The original Flolan brand was discontinued in November 2025 after patients were transitioned to other formulations or therapies. The discontinuation did not mean that epoprostenol itself had been declared ineffective or unsafe.
What Is Epoprostenol?
Epoprostenol is a laboratory-made version of prostacyclin, a naturally occurring substance produced within blood vessel walls. Prostacyclin helps blood vessels relax and discourages platelets from sticking together. In pulmonary arterial hypertension, those actions can make it easier for blood to move through narrowed pulmonary arteries.
The medicine has two principal pharmacologic effects: it dilates pulmonary and systemic arteries, and it inhibits platelet aggregation. By reducing resistance within the pulmonary circulation, epoprostenol can lower the workload placed on the right ventricle, the chamber responsible for pumping blood into the lungs.
Why the Infusion Must Be Continuous
Epoprostenol disappears from the bloodstream remarkably quickly. Its expected half-life in human blood is no longer than about six minutes. In practical terms, the medication does not leave much of a safety cushion when the pump stops. The body begins losing its effect rapidly, which is why the infusion runs 24 hours a day rather than arriving as an occasional injection.
This short half-life explains the seriousness of pump alarms, blocked tubing, an empty cassette, accidental disconnection, or catheter damage. The pump may be small, but it is not merely a fussy electronic accessory. It is continuously delivering a life-sustaining medication.
What Is Epoprostenol Used For?
Veletri is FDA-approved to improve exercise capacity in people with pulmonary arterial hypertension, also known as WHO Group 1 pulmonary hypertension. The clinical studies supporting approval primarily included people with more advanced symptoms, especially New York Heart Association functional Class III or IV disease caused by idiopathic PAH, heritable PAH, or PAH associated with connective tissue disease.
PAH is not simply ordinary high blood pressure that wandered into the lungs. It involves abnormal narrowing and remodeling of the small pulmonary arteries. The right side of the heart must push against that resistance, potentially leading to fatigue, dizziness, shortness of breath, fainting, swelling, and right-sided heart failure.
Epoprostenol is not automatically appropriate for every form of pulmonary hypertension. Pulmonary hypertension caused mainly by left-sided heart disease, chronic lung disease, blood clots, or other complex mechanisms requires a diagnosis-specific treatment plan. Specialized evaluation is essential because therapies that help one pulmonary hypertension group may be ineffective or hazardous in another.
Does Epoprostenol Cure PAH?
No. PAH currently has no simple cure, and epoprostenol does not permanently reverse every underlying blood-vessel change. It is a disease-controlling treatment intended to improve circulation, symptoms, exercise capacity, and clinical stability. Research and historical trials have also made intravenous epoprostenol an important therapy for people with high-risk or advanced PAH.
Epoprostenol Dosing and Administration
Epoprostenol dosing is expressed in nanograms per kilogram per minute. That is an extremely small quantity adjusted for body weight and delivered continuously. The prescribed dose is converted into a pump rate based on the prepared solution’s concentration. Pharmacy and pulmonary hypertension professionals perform and verify these calculations; this is not a sensible place for improvisational mathematics.
Starting Veletri
According to current U.S. labeling, chronic Veletri infusion is generally started at 2 ng/kg/min. During supervised initiation, the rate may be increased by 2 ng/kg/min at intervals of 15 minutes or longer until a tolerable and clinically appropriate dose is reached. A lower starting rate may be used when 2 ng/kg/min is not tolerated. Initiation occurs where blood pressure, heart rate, symptoms, and emergency needs can be closely monitored.
Long-Term Dose Adjustments
There is no universal “perfect maintenance dose.” Requirements differ significantly among patients and may change over time. When PAH symptoms persist, return, or worsen, the label allows clinician-directed increases of 1 to 2 ng/kg/min, with sufficient time to assess the response. Dose-limiting side effects may require gradual reductions.
After a new infusion rate is established, monitoring may include seated, standing, and lying blood pressure measurements, heart rate checks, symptom review, exercise tolerance, laboratory tests, echocardiography, and other PAH assessments. Dose adjustments should occur only under a physician’s direction. Abruptly turning the rate down because a headache is annoying can trade one problem for a far more dangerous one.
How the Medication Is Delivered
For chronic treatment, Veletri is administered through an indwelling central venous catheter connected to a portable infusion pump. A temporary peripheral IV may sometimes be used until central access is established. The pump must meet specific accuracy and alarm requirements, including alarms for blockage, low battery, and the end of an infusion.
Patients and caregivers receive detailed training in medication preparation, cassette changes, pump operation, catheter care, sterile technique, alarm response, and emergency procedures. Only the approved diluents and preparation instructions for the exact product should be used. Veletri and older Flolan formulations are not automatically interchangeable during preparation because their diluents, stability requirements, equipment, and instructions may differ.
Epoprostenol Pictures and Appearance
Veletri is supplied as a white to off-white freeze-dried powder in a single-dose 10 mL vial. Under the current label, the 0.5 mg Veletri vial has a white flip-off seal, while the 1.5 mg vial has a red flip-off seal. The outer carton displays the brand name, strength, intravenous-use statement, and National Drug Code.
After preparation, the solution must be inspected whenever possible. It should not be used if unexpected particles or discoloration are visible. However, product pictures, cap colors, and internet photographs should never be the only methods used to identify medication. Packaging can change, generic products may look different, and a tired person changing a cassette at 2:00 a.m. deserves a more dependable system than “the vial looked familiar.” Always confirm the name, strength, expiration date, pharmacy label, and written preparation instructions.
Common Epoprostenol Side Effects
Many epoprostenol side effects are extensions of its vasodilating action. In plain English, widening blood vessels helps circulation but can also produce symptoms when the effect is stronger than the body comfortably appreciates.
- Headache
- Facial flushing or warmth
- Jaw pain, especially when beginning to chew
- Nausea or vomiting
- Diarrhea or abdominal discomfort
- Dizziness or lightheadedness
- Low blood pressure
- Muscle, bone, back, or generalized body pain
- Flu-like feelings
- Anxiety, nervousness, or restlessness
- Fast or slow heart rate
Jaw pain is a particularly recognizable prostacyclin effect. Some patients describe the first few bites of a meal as surprisingly uncomfortable before the sensation eases. It is medically less dramatic than a pump failure, but it can make a sandwich feel as if it has arrived with terms and conditions.
Side Effects During Dose Increases
Flushing, headache, nausea, vomiting, hypotension, dizziness, chest discomfort, abdominal pain, shortness of breath, and heart-rate changes can appear or become stronger during initiation or upward titration. Persistent or severe symptoms should be reported rather than silently endured. The specialist may need to evaluate whether the dose, rate of titration, PAH itself, another medication, dehydration, infection, or a separate condition is responsible.
Serious Side Effects and Emergency Warnings
Rebound Pulmonary Hypertension
A sudden interruption or major reduction in epoprostenol can cause rapid worsening of PAH. Warning symptoms may include increased breathlessness, dizziness, weakness, chest discomfort, fainting, or collapse. Treatment interruption has been associated with death, so a pump failure or disconnection requires immediate use of the patient’s emergency plan and contact with the specialty team.
Pulmonary Edema
New or rapidly worsening breathing difficulty, cough, chest congestion, low oxygen, or fluid accumulation in the lungs can indicate pulmonary edema. Development of pulmonary edema during initiation may suggest pulmonary veno-occlusive disease, a condition in which epoprostenol can be dangerous. The prescribing information advises against chronic use when pulmonary edema develops during dose initiation.
Catheter or Bloodstream Infection
A central catheter creates a possible pathway for microorganisms to enter the bloodstream. Fever, chills, unusual fatigue, redness, drainage, warmth, swelling, or pain near the catheter site require prompt medical attention. Infection symptoms can resemble flu-like medication effects, so guessing is a poor diagnostic strategy. When in doubt, contact the PAH team.
Bleeding
Because epoprostenol reduces platelet aggregation, unusual bruising or bleeding should be reported. Urgent warning signs include vomiting blood, coughing blood, black stools, blood in urine, bleeding that will not stop, or sudden neurologic symptoms.
Severe Low Blood Pressure or Excessive Dose
Too much epoprostenol may cause marked flushing, severe headache, nausea, vomiting, diarrhea, rapid heartbeat, faintness, confusion, profound hypotension, or loss of consciousness. Never independently stop the pump in response. Emergency professionals and the PAH specialist must coordinate any intervention because both excessive delivery and sudden withdrawal are dangerous.
Epoprostenol Drug Interactions
Medication interaction reviews should include prescriptions, nonprescription drugs, vitamins, supplements, and recreational substances. Particularly important categories include:
- Blood pressure medications, diuretics, and other vasodilators: These combinations may produce additional blood pressure reduction, dizziness, or fainting.
- Anticoagulants and antiplatelet drugs: Medicines such as warfarin, heparin, apixaban, clopidogrel, or aspirin may add to bleeding risk. Some combinations are deliberately prescribed, but they require professional supervision.
- Digoxin: Digoxin concentrations may rise after epoprostenol is started, which can be important in patients susceptible to digoxin toxicity.
- Other PAH therapies: Epoprostenol is frequently part of combination treatment, but the combined effects on blood pressure and circulation require coordinated monitoring.
The presence of a potential interaction does not automatically mean two drugs can never be used together. It means the prescriber needs to consider dosing, monitoring, bleeding risk, blood pressure, and the patient’s overall treatment plan.
Contraindications and Special Warnings
Severe Left Ventricular Systolic Heart Failure
Chronic Veletri use is contraindicated in congestive heart failure caused by severe left ventricular systolic dysfunction. A major study in that population was stopped after higher mortality was found among patients receiving epoprostenol plus conventional treatment. This distinction is one reason an exact pulmonary hypertension diagnosis matters so much.
Allergy
The medication should not be used in people with known hypersensitivity to epoprostenol or structurally related compounds. Facial swelling, hives, throat tightness, or sudden difficulty breathing requires emergency care.
Pregnancy and Breastfeeding
Available published pregnancy information has not established a clear medication-associated risk of major birth defects or miscarriage, but the evidence is limited. Untreated PAH itself poses severe risks during pregnancy, including heart failure, stroke, premature delivery, and maternal or fetal death. Pregnancy planning therefore requires early coordination among PAH, maternal-fetal medicine, cardiology, anesthesia, and pharmacy specialists. There are no adequate data showing whether epoprostenol is present in human milk.
Children and Older Adults
Safety and effectiveness have not been established in pediatric patients under the current Veletri label, although specialists may use prostacyclin therapies in selected children. Clinical trials also included too few adults aged 65 and older to identify reliable age-specific differences, so cautious individualized dosing is appropriate.
Living Safely With an Epoprostenol Pump
Successful epoprostenol treatment combines medication science with excellent logistics. Patients generally keep a backup pump, extra batteries, medication supplies, sterile catheter-care materials, written dosing information, emergency telephone numbers, and enough equipment to manage delays or travel disruptions.
Emergency responders, family members, coworkers, and travel companions should know that the infusion must not be stopped and that the dedicated catheter should not be used for unrelated medications unless the PAH team specifically directs it. A medical alert card or bracelet can communicate this when the patient cannot.
Daily Safety Checklist
- Confirm that the pump is running at the prescribed rate.
- Check battery life, medication volume, tubing, connections, and alarms.
- Inspect the catheter dressing and surrounding skin.
- Keep the site clean and dry according to the care team’s protocol.
- Carry backup equipment whenever leaving home.
- Know exactly whom to call for a pump, catheter, or medication emergency.
- Request refills early rather than testing the limits of overnight shipping.
Experiences With Epoprostenol: What Daily Treatment Can Feel Like
The following discussion combines commonly reported practical themes from pulmonary hypertension education resources. It is not a quotation or personal story from one identifiable patient.
Beginning epoprostenol often feels like learning a new household operating system while simultaneously recovering from a serious illness. During the first days, patients may be processing the diagnosis, catheter placement, pump instructions, sterile preparation steps, side effects, insurance calls, and the unsettling realization that the medication cannot simply be skipped on a busy morning.
Training usually becomes easier through repetition. At first, preparing supplies may require a written checklist and intense concentration. Hands are washed, surfaces are cleaned, packages are opened without contaminating sterile components, medication labels are checked, and connections are inspected. After practice, the routine may become more familiar, although familiarity should never turn into carelessness. Sterile technique remains essential even when the person could practically recite the instructions in their sleep.
The pump also becomes a constant companion. Patients learn how to wear it under clothing, carry it in a pouch, position tubing during sleep, and protect the catheter during normal movement. Clothing choices may change. Showers require a catheter-protection system approved by the treatment team. Sleeping may involve arranging tubing so that it is neither pulled nor trapped beneath the body. These details rarely appear in a glamorous medication advertisement, yet they can dominate the early adjustment period.
Side effects add another layer. Headache, flushing, diarrhea, nausea, body pain, or jaw discomfort may increase after titration. People often begin recognizing patterns: jaw pain with the first bites of food, flushing shortly after a dose increase, or lightheadedness when standing too quickly. A symptom diary can help the specialist distinguish predictable medication effects from worsening PAH, dehydration, infection, or excessive vasodilation.
Many patients describe a strange balance between inconvenience and improvement. The pump may complicate showering, dressing, work, sleep, and travel, yet better circulation may make walking, talking, shopping, or climbing a few stairs less exhausting. Improvements are not identical or guaranteed, and the medication does not erase PAH. Still, gaining enough stamina to participate more fully in ordinary life can make the equipment feel less like an intruder and more like an demanding but useful teammate.
Travel becomes possible with planning rather than spontaneity. A person may carry twice the expected number of supplies, keep medication and equipment in hand luggage, bring letters for airport security, identify specialty pharmacies and hospitals near the destination, and teach a companion what to do if the pump alarms. Missed flights become annoying for everyone; for someone dependent on continuous infusion, they can become a supply-management event.
Work also requires practical conversations. Some patients tell a supervisor or trusted coworker about the pump and emergency instructions. Others arrange a clean, private area for medication-related tasks. Jobs involving water, heavy physical activity, contamination, extreme temperature, or remote locations may require modifications. The objective is not to surrender independence but to redesign routines around a treatment that has very little patience for chaos.
The emotional adjustment can be substantial. Pump alarms may trigger anxiety even when the cause is merely a low battery. Patients may feel self-conscious about visible tubing or frustrated by dependence on equipment. Caregivers may worry about making a preparation error. Support groups, experienced infusion nurses, PAH centers, and patient organizations can help normalize those concerns and offer practical solutions that a package insert cannot provide.
Over time, many households develop an organized system: one location for sterile supplies, another for emergency equipment, calendar reminders for refills, checklists near the preparation area, and backup information stored on multiple phones. The process may never become effortless, but it often becomes manageable. The central lesson is that successful treatment is not based on bravery or perfect memory. It is based on training, redundancy, communication, and asking for help before a small equipment problem becomes a medical emergency.
Frequently Asked Questions
Can epoprostenol be taken as a pill?
No. Veletri is formulated for continuous intravenous infusion. Other medications targeting the prostacyclin pathway are available in oral, inhaled, intravenous, or subcutaneous forms, but they are not simple dose-for-dose substitutes.
What happens if the pump briefly stops?
Because epoprostenol has an extremely short half-life, even a brief interruption may cause symptoms to return rapidly. Follow the emergency plan provided by the PAH center, use the backup equipment exactly as trained, and contact the specialty team immediately.
Can I disconnect the pump to shower?
Patients should not disconnect the infusion for bathing. The catheter and pump must be protected using methods specifically taught or approved by the care team.
Is inhaled epoprostenol the same treatment?
No. Hospitals sometimes use inhaled epoprostenol off-label in critical-care situations. Veletri’s approved PAH administration is continuous intravenous infusion, and an inhaled hospital protocol should not be confused with a patient’s labeled home infusion.
Can Veletri and Flolan be mixed using the same instructions?
No assumption of interchangeability should be made. Formulations can have different approved diluents, stability conditions, storage requirements, concentrations, and equipment instructions. Use only the written directions supplied for the exact product dispensed.
Conclusion
Epoprostenol is among the most intensive treatments used for pulmonary arterial hypertension, but it is also an important option for people whose disease requires powerful, continuously delivered prostacyclin therapy. It works by relaxing pulmonary blood vessels and reducing platelet aggregation, helping the heart move blood through the lungs more effectively.
The medication’s short half-life makes uninterrupted delivery essential. Safe use depends on specialist-guided dosing, meticulous catheter care, sterile preparation, backup equipment, interaction monitoring, and a rehearsed emergency plan. Common effects such as flushing, headache, jaw pain, nausea, and diarrhea may be manageable, while pulmonary edema, severe hypotension, infection, bleeding, or sudden worsening of breathlessness require urgent evaluation.
Veletri remains a current U.S. epoprostenol product, while the Flolan brand was discontinued in 2025. Patients previously familiar with Flolan should follow the instructions for their current formulation rather than relying on old preparation habits. With training, support, and a well-organized supply system, continuous infusion can become a workable part of daily lifeeven if the pump insists on being the most demanding member of the household.
